Gainers Tenax Therapeutics Inc (NASDAQ: TENX) shares climbed 42.3% to $2.07 after the company reported results from its Phase 2 trial of Levosimendan. The trial demonstrated a significant reduction in right atrial and pulmonary capillary wedge pressures.
Benzinga · 1天前
EV Company News For The Month Of May 2020
Seeking Alpha - Article · 4天前
Tata Motors Trading Near All-Time Low Ahead Of Earnings
Seeking Alpha - Article · 5天前
China's Chery Auto plans to sell cars in EU, United States: chairman
Reuters · 05/27 10:32
After shortages, Britain opens new protective equipment supply lines
Reuters · 05/26 20:33
Project Birch: Treasury draws up last resort bailout plan to rescue Britains largest companies